A citation-based method for searching scientific literature

A Sánchez-González, E Thougaard, C Tapias-Espinosa, T Cañete, D Sampedro-Viana, J M Saunders, R Toneatti, A Tobeña, J Gónzalez-Maeso, S Aznar, A Fernández-Teruel. Eur Neuropsychopharmacol 2021
Times Cited: 4







List of co-cited articles
49 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia.
Kuei Y Tseng, R Andrew Chambers, Barbara K Lipska. Behav Brain Res 2009
233
50


Volumetric brain differences between the Roman rat strains: Neonatal handling effects, sensorimotor gating and working memory.
Cristóbal Río-Álamos, Maria A Piludu, Cristina Gerbolés, Didac Barroso, Ignasi Oliveras, Ana Sánchez-González, Toni Cañete, Carles Tapias-Espinosa, Daniel Sampedro-Viana, Rafael Torrubia,[...]. Behav Brain Res 2019
14
50

Hippocampal synaptic plasticity, spatial memory and anxiety.
David M Bannerman, Rolf Sprengel, David J Sanderson, Stephen B McHugh, J Nicholas P Rawlins, Hannah Monyer, Peter H Seeburg. Nat Rev Neurosci 2014
349
50

Early-life handling stimulation and environmental enrichment: are some of their effects mediated by similar neural mechanisms?
Alberto Fernández-Teruel, Lydia Giménez-Llort, Rosa M Escorihuela, Luis Gil, Raúl Aguilar, Thierry Steimer, Adolf Tobeña. Pharmacol Biochem Behav 2002
124
50


Neonatal handling enduringly decreases anxiety and stress responses and reduces hippocampus and amygdala volume in a genetic model of differential anxiety: Behavioral-volumetric associations in the Roman rat strains.
Cristóbal Río-Álamos, Ignasi Oliveras, Maria Antonietta Piludu, Cristina Gerbolés, Toni Cañete, Gloria Blázquez, Silvia Lope-Piedrafita, Esther Martínez-Membrives, Rafael Torrubia, Adolf Tobeña,[...]. Eur Neuropsychopharmacol 2017
19
50

Neonatal handling decreases unconditioned anxiety, conditioned fear, and improves two-way avoidance acquisition: a study with the inbred Roman high (RHA-I)- and low-avoidance (RLA-I) rats of both sexes.
Cristóbal Río-Ȧlamos, Ignasi Oliveras, Toni Cañete, Gloria Blázquez, Esther Martínez-Membrives, Adolf Tobeña, Alberto Fernández-Teruel. Front Behav Neurosci 2015
22
50

Regional dissociations within the hippocampus--memory and anxiety.
D M Bannerman, J N P Rawlins, S B McHugh, R M J Deacon, B K Yee, T Bast, W-N Zhang, H H J Pothuizen, J Feldon. Neurosci Biobehav Rev 2004
983
50

Schizophrenia-like reduced sensorimotor gating in intact inbred and outbred rats is associated with decreased medial prefrontal cortex activity and volume.
Carles Tapias-Espinosa, Cristóbal Río-Álamos, Ana Sánchez-González, Ignasi Oliveras, Daniel Sampedro-Viana, Maria Del Mar Castillo-Ruiz, Toni Cañete, Adolf Tobeña, Alberto Fernández-Teruel. Neuropsychopharmacology 2019
17
50



Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.
José L Moreno, Terrell Holloway, Laura Albizu, Stuart C Sealfon, Javier González-Maeso. Neurosci Lett 2011
126
50

Role of mGlu2 in the 5-HT2A receptor-dependent antipsychotic activity of clozapine in mice.
Kelsey S Hideshima, Ashkhan Hojati, Justin M Saunders, Doan M On, Mario de la Fuente Revenga, Jong M Shin, Ana Sánchez-González, Cassandra M Dunn, Alexander B Pais, Anthony C Pais,[...]. Psychopharmacology (Berl) 2018
7
50

Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.
Natalie Hesselgrave, Timothy A Troppoli, Andreas B Wulff, Anthony B Cole, Scott M Thompson. Proc Natl Acad Sci U S A 2021
12
50


Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.
Roland R Griffiths, Matthew W Johnson, Michael A Carducci, Annie Umbricht, William A Richards, Brian D Richards, Mary P Cosimano, Margaret A Klinedinst. J Psychopharmacol 2016
411
50

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
Alan K Davis, Frederick S Barrett, Darrick G May, Mary P Cosimano, Nathan D Sepeda, Matthew W Johnson, Patrick H Finan, Roland R Griffiths. JAMA Psychiatry 2021
73
50

Psychedelics.
David E Nichols. Pharmacol Rev 2016
363
50

The STAR*D trial: revealing the need for better treatments.
Thomas R Insel, Philip S Wang. Psychiatr Serv 2009
83
50

Psychedelics Promote Structural and Functional Neural Plasticity.
Calvin Ly, Alexandra C Greb, Lindsay P Cameron, Jonathan M Wong, Eden V Barragan, Paige C Wilson, Kyle F Burbach, Sina Soltanzadeh Zarandi, Alexander Sood, Michael R Paddy,[...]. Cell Rep 2018
175
50

Classical hallucinogens: an introductory overview.
R A Glennon. NIDA Res Monogr 1994
22
50

Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression.
Meghan Hibicke, Alexus N Landry, Hannah M Kramer, Zoe K Talman, Charles D Nichols. ACS Chem Neurosci 2020
19
50

Histone acetylation: molecular mnemonics on the chromatin.
Johannes Gräff, Li-Huei Tsai. Nat Rev Neurosci 2013
335
50

Animal models of serotonergic psychedelics.
James B Hanks, Javier González-Maeso. ACS Chem Neurosci 2013
71
50

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.
Robin L Carhart-Harris, Mark Bolstridge, James Rucker, Camilla M J Day, David Erritzoe, Mendel Kaelen, Michael Bloomfield, James A Rickard, Ben Forbes, Amanda Feilding,[...]. Lancet Psychiatry 2016
377
50

Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling.
Kelly A Jones, Deepak P Srivastava, John A Allen, Ryan T Strachan, Bryan L Roth, Peter Penzes. Proc Natl Acad Sci U S A 2009
112
50

Essential role of the histone methyltransferase G9a in cocaine-induced plasticity.
Ian Maze, Herbert E Covington, David M Dietz, Quincey LaPlant, William Renthal, Scott J Russo, Max Mechanic, Ezekiell Mouzon, Rachael L Neve, Stephen J Haggarty,[...]. Science 2010
441
50

Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.
Javier González-Maeso, Noelia V Weisstaub, Mingming Zhou, Pokman Chan, Lidija Ivic, Rosalind Ang, Alena Lira, Maria Bradley-Moore, Yongchao Ge, Qiang Zhou,[...]. Neuron 2007
430
50

Effects of N, N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression.
Lindsay P Cameron, Charlie J Benson, Lee E Dunlap, David E Olson. ACS Chem Neurosci 2018
40
50

A microfluidic device for epigenomic profiling using 100 cells.
Zhenning Cao, Changya Chen, Bing He, Kai Tan, Chang Lu. Nat Methods 2015
68
50

Molecular mechanisms of dendrite stability.
Anthony J Koleske. Nat Rev Neurosci 2013
220
50



The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).
Ronald C Kessler, Patricia Berglund, Olga Demler, Robert Jin, Doreen Koretz, Kathleen R Merikangas, A John Rush, Ellen E Walters, Philip S Wang. JAMA 2003
50

Trial of Psilocybin versus Escitalopram for Depression.
Robin Carhart-Harris, Bruna Giribaldi, Rosalind Watts, Michelle Baker-Jones, Ashleigh Murphy-Beiner, Roberta Murphy, Jonny Martell, Allan Blemings, David Erritzoe, David J Nutt. N Engl J Med 2021
48
50

Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing.
L S Kaertner, M B Steinborn, H Kettner, M J Spriggs, L Roseman, T Buchborn, M Balaet, C Timmermann, D Erritzoe, R L Carhart-Harris. Sci Rep 2021
9
50


Fully automated head-twitch detection system for the study of 5-HT2A receptor pharmacology in vivo.
Mario de la Fuente Revenga, Jong M Shin, Hiba Z Vohra, Kelsey S Hideshima, Matthew Schneck, Justin L Poklis, Javier González-Maeso. Sci Rep 2019
6
50

Chromatin Regulation in Complex Brain Disorders.
Ryan M Bastle, Ian Maze. Curr Opin Behav Sci 2019
9
50

Synaptic dysfunction in depression: potential therapeutic targets.
Ronald S Duman, George K Aghajanian. Science 2012
711
50

Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects.
Yasmin Schmid, Florian Enzler, Peter Gasser, Eric Grouzmann, Katrin H Preller, Franz X Vollenweider, Rudolf Brenneisen, Felix Müller, Stefan Borgwardt, Matthias E Liechti. Biol Psychiatry 2015
167
50

Smart-seq2 for sensitive full-length transcriptome profiling in single cells.
Simone Picelli, Åsa K Björklund, Omid R Faridani, Sven Sagasser, Gösta Winberg, Rickard Sandberg. Nat Methods 2013
50

Full-length RNA-seq from single cells using Smart-seq2.
Simone Picelli, Omid R Faridani, Asa K Björklund, Gösta Winberg, Sven Sagasser, Rickard Sandberg. Nat Protoc 2014
50

A non-hallucinogenic psychedelic analogue with therapeutic potential.
Lindsay P Cameron, Robert J Tombari, Ju Lu, Alexander J Pell, Zefan Q Hurley, Yann Ehinger, Maxemiliano V Vargas, Matthew N McCarroll, Jack C Taylor, Douglas Myers-Turnbull,[...]. Nature 2021
31
50

The molecular neurobiology of depression.
Vaishnav Krishnan, Eric J Nestler. Nature 2008
50

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.
F X Vollenweider, M F Vollenweider-Scherpenhuyzen, A Bäbler, H Vogel, D Hell. Neuroreport 1998
437
50

MOWChIP-seq for low-input and multiplexed profiling of genome-wide histone modifications.
Bohan Zhu, Yuan-Pang Hsieh, Travis W Murphy, Qiang Zhang, Lynette B Naler, Chang Lu. Nat Protoc 2019
11
50

Approach-withdrawal and the role of the striatum in the temperament of behavioral inhibition.
Sarah M Helfinstein, Nathan A Fox, Daniel S Pine. Dev Psychol 2012
25
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.